HCM HUTCHMED (China) Limited Earnings per share growth rate in current year

Official company branding of hutch-med.com (HCM)

Year-over-year EPS growth percentages in daily price action on the GURU.Markets chart demonstrate a trend where the -84.80 indicator determines the parameter status. Biopharmaceutical giant HUTCHMED (China) Limited (HCM) is implementing energy-efficient plants with water purification to comply with ESG standards. A proprietary high-tech network of laboratories in China ensures operational stability, although risks of capital burn and approval delays in the US persist.

HCM: HUTCHMED (China) Limited Earnings per share growth in current year 07/04/2022 - 11/17/2026

Comprehensive metric breakdowns and analytics for HUTCHMED Corp (HCM)

- price and consensus price forecast:
Summary company analysis:HUTCHMED (China) Limited (HCM)
Original product of HUTCHMED Ltd

HUTCHMED (China) Limited's proprietary high-tech oncology manufacturing capacities guarantee operational resilience, which directly impacts net profit dynamics. By analyzing the year-over-year percentage change in EPS, an investor assesses the growth rate of earnings per share relative to the previous period, identifying the business's fundamental strength and its competitiveness within the sector to minimize the risks of a deep asset write-down.

Key competitors

Earnings per share growth this year INCY|NUVB (nuvationbio.com) - Earnings growth in current year|Net earnings per share growth this year dayonebio.com (DAWN)|Earnings per share growth in current year Monopar Corp (MNPR)|INBX - Earnings per share growth rate in current year|Earnings per share growth in current year I-Mab Inc. IMAB|Fennec - Earnings per share growth in current year|HRTX - Earnings per share growth in current year|Earnings per share growth rate in current year Nuvectis Pharma, Inc.|CHRS: Earnings growth in current year|Net earnings per share change in current year Corbus Pharma CRBP|Net earnings per share growth this year CRDF|Earnings per share growth rate in current year BeyondSpring Inc. BYSI|Net earnings per share growth this year BCAB (BioAtla Inc)|LIXT (Lixte Biotechnology Holdings, Inc.) - Earnings per share increase in current year|Citius Pharmaceuticals, Inc. - Net earnings per share growth this year|Net earnings per one share growth for the current year CLRB (Cellectar Biosciences, Inc.)|BioLineRx Corp - Earnings growth in current year|Earnings per share increase in current year CANF (Can-Fite BioPharma, Ltd.)|APRE: Earnings growth in current year|Earnings per share growth rate in current year Kazia (KZIA)|Earnings per share growth in current year silexion.com|NCNA: Earnings per share increase in current year|Earnings growth in current year CMRX|Earnings growth in current year Cyclacel, Inc. (CYCC)|Earnings per share growth in current year G1 Therapeutics Inc. GTHX|KRON (Kronos Bio) - Earnings per share trend in current year|KTRA: Net earnings per share growth this year|Earnings per share growth rate in current year Oncternal Therapeutics Inc|Portage Biotech (PRTG) - Earnings per share growth in current year